European ERA-Net Consortium on single cell Transcriptomics in CSF

Diseases named “Autoimmune Encephalitis” (AIE) are increasingly recognized as immune-mediated disorder of the gray matter (i.e. the neurons) of the central nervous system (CNS). AIE is rare, but often severely disabling and potentially lethal. In this proposal we aim to study why the immune system erroneously targets auto-immunity against neurons and synapses by integrating data from multiple novel transcriptomic and proteomic techniques.

We previously found a small number of markers that are predictive for the disease, but a full-scale unbiased characterization of autoimmunity in AIE has not been performed. We here propose to characterize the cell types, markers, pathways and genes that are specific to AIE with extremely high resolution and precision. We are a unique and focused group of clinicians and researchers from multiple countries (The Netherlands, Germany, Israel) and multiple centres (Rotterdam, Münster, Kiel, Rechovot) treating and studying a large cohort of AIE patients. We also manage large biomaterial banks. We have also developed and calibrated new genomic technologies to construct very detailed models of immune cells and pathways in autoimmune diseases. Our group thus combines cutting-edge technology with access to rare clinical specimen and a long-standing expertise in diagnosing this heterogeneous disorder. This will enable us to better understand how immune cells interact with the inflamed brain.

This outstanding combination of world leading scientists and clinicians with new technologies makes us especially well equipped to break new grounds in AIE research. We propose that an ultra-high resolution phenotyping of local immune responses, using single cell genomic analysis of the CSF will provide a basis for better understanding, diagnosing, predicting and treating AIE in the future.

Figure 1 diagnostic workflow in scRNA-seq of CSF cells

Figure 1: Illustration of diagnostic workflow in scRNA-seq of CSF cells, that identifies MS-specific changes. (A) CSF cells were collected form 5 controls and 5 multiple sclerosis (MS) patients. (B) Dimensionality reduction using tSNE was performed. Modified from PubMed ID 31937773.




PD Dr. med. Gerd Meyer zu Hörste
Oberarzt und Arbeitsgruppenleiter

Klinik für Neurologie mit

Institut für Translationale Neurologie
Universitätsklinikum Münster
Albert-Schweitzer-Campus 1, Gebäude A1
48149 Münster


Prof. Dr. Maarten Titulaer

Erasmus University
Department of Neurology
s-Gravendijkwal 230
3015 CE Rotterdam, Netherlands


Prof. Ido Amit
Principal Investigator

Weizmann Institute of Science
Department of Immunology
Wolfson Building for Biological Research
Rehovot, 76100, Israel


PD Dr. med. Frank Leypoldt
Facharzt für Neurologie, Facharzt für Laboratoriumsmedizin, Leitung Neuroimmunologische Ambulanz

Institut für Klinische Chemie
Universitätsklinikum Schleswig-Holstein
Arnold-Heller-Str. 3 (Haus U30)
24105 Kiel


PD Dr. med. Nico Melzer
Oberarzt, Arbeitsgruppenleiter

Klinik und Poliklinik für Neurologie mit Institut für Translationale Neurologie
Westfälische Wilhelms-Universität Münster
Albert-Schweizer-Campus 1, Gebäude A1
48149 Münster



Find a center near you here.

Latest news

Upcoming events


Der GENERATE e.V. plant anlässlich des Welt-Enzephalitis-Tages am 22.2.2021 (Montag) um 16.00 Uhr ein Patientenforum. Die Veranstaltung soll als Webinar stattfinden und richtet sich an Patientinnen und Patienten mit Autoimmun-Enzephalitis sowie deren Angehörigen. Hier können Betroffene sich über Neues aus Diagnostik und Therapie sowie über die Gründung einer Selbsthilfegruppe für Autoimmun-Enzephalitis informieren.


Hansen N, Schwing K, Önder D, et al. Epilepsy Behav. 2020;102:106682.

Bracher A, Alcalá C, Ferrer J, et al. Ann Clin Transl Neurol. 2020;7(2):239‐244.

Bien CG, Bien CI, Dogan Onugoren M, et al. [published online ahead of print, 2020 Apr 3] [published correction appears in J Neurol. 2020 May 12;:]. J Neurol. 2020;10.1007/s00415-020-09814-3.

Kornau HC, Kreye J, Stumpf A, et al. Ann Neurol. 2020;87(3):405‐418

Steiner J, Prüss H, Köhler S, Frodl T, Hasan A, Falkai P. World J Biol Psychiatry. 2020;21(4):241‐254.